Get Updates

Making Sense of Cancer Headlines

FORCE's XRAYS program, funded by the CDC, is a reliable resource for young breast cancer survivors and high-risk women to navigate through breast cancer research related news and information.

XRAYS logo and women

Intimacy & Body Image

Be a Part of XRAYS

XRAYS: Making Sense of Cancer Headlines


About the XRAYS Program

FORCE developed our eXamining the Relevance of Articles for Young Survivors (XRAYS) program to empower young breast cancer survivors and high-risk women by providing tools for evaluating reports of new breast cancer-related research. Funded by the CDC, XRAYS will provide reviews and ratings of news media articles on breast cancer research to help young breast cancer survivors better understand research that is relevant to them. Learn more about the XRAYS program

XRAYS Rating

STUDY: Does scalp cooling help prevent hair loss after chemotherapy for breast cancer?

Hair loss is one of the most recognized and distressing side effects of some chemotherapies. Two new studies looked at the use of scalp cooling therapy to help reduce hair loss after chemotherapy for early-stage breast cancer. (5/15/17)

XRAYS Rating

ARTICLE: After mastectomy: reconstruct or not?

Today, more women know they can have breast reconstruction after removing their breasts for cancer treatment or risk reduction. But what about choosing not to undergo reconstruction? Roni Caryn Rabin writes about the experiences of women who decide against reconstruction in her New York Times piece “‘Going Flat’ After Breast Cancer.” (12/14/16)

XRAYS Rating

STUDY: Vaginal estrogen may be used in women who have been treated for ER-positive breast cancer

After breast cancer treatment, some women experience vaginal dryness, urinary tract problems and other survivorship issues. Vaginal estrogen creams, rings and tablets effectively address these symptoms in menopausal women; however, there is concern that vaginal estrogen may not be safe for women with a history of estrogen-dependent (ER+) breast cancer. A recent opinion from the American College of Obstetricians and Gynecologists Committee on Gynecologic Practice states that, based on available data, vaginal estrogen should be safe to use for women if nonhormonal approaches do not alleviate their symptoms. (3/29/16)

Back to XRAYS Home

Find older XRAYS studies and articles

By keyword search:

By date range:

By quarterly digest:

FORCE:Facing Our Risk of Cancer Empowered